CSTL R&D Expenses
Castle Biosciences Inc · R&D Expenses
CSTL R&D Expenses
Latest reported$55.45Mperiod ending
CSTL TTM R&D Expenses ($4.85M → $55.45M)
TTM R&D Expenses
High-resolution chart · PNG
CSTL r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 55,446,000 | |
| 53,690,000 | |
| 51,850,000 | |
| 50,012,000 | |
| 49,375,000 | |
| 50,724,000 | |
| 51,945,000 | |
| 53,262,000 | |
| 53,862,000 | |
| 53,034,000 | |
| 53,618,000 | |
| 51,933,000 | |
| 49,917,000 | |
| 48,535,000 | |
| 44,903,000 | |
| 43,039,000 | |
| 39,632,000 | |
| 34,499,000 | |
| 29,646,000 | |
| 24,782,000 | |
| 20,340,000 | |
| 16,251,000 | |
| 13,256,000 | |
| 11,833,946 | |
| 10,290,912 | |
| 8,904,149 | |
| 7,385,000 | |
| 5,364,098 | |
| 5,143,433 | |
| 4,985,393 | |
| 4,854,232 |